Insulin biosimilar (Julphar)

胰岛素生物类似药 (Julphar)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInsulin biosimilar (Julphar)
Drug Alias NameSoluble human insulin biosimilar - Julphar胰岛素生物仿制药 (Julphar)Recombinant human insulin - JulpharRegular insulin human biosimilar - JulpharJulphar Insulin R
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsDiabetes Mellitus
Approved Indications in ChinaN/A
Original Approved Country/TerritoryTunisia
Original Approved Date2013/10/01
Country/TerritoryUnited StatesTunisiaGermany
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesJulphar (Gulf Pharmaceutical Industries)
China Registration ClassN/A

Develop Information

Active CompaniesLaboratorios Pisa SA de CVJulphar (Gulf Pharmaceutical Industries)
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeA10AB01A10AC01A10AD01 +[5] 
Related LinksN/A